BrightGene Bio (China) Price on June 5, 2023

688166 Stock   29.55  0.68  2.36%   
Below is the normalized historical share price chart for BrightGene Bio Medical extending back to November 08, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BrightGene Bio stands at 29.55, as last reported on the 15th of January 2025, with the highest price reaching 29.68 and the lowest price hitting 28.72 during the day.
200 Day MA
30.7918
50 Day MA
31.5174
Beta
0.386
 
Covid
If you're considering investing in BrightGene Stock, it is important to understand the factors that can impact its price. At this point, BrightGene Bio is not too volatile. BrightGene Bio Medical secures Sharpe Ratio (or Efficiency) of 0.0029, which signifies that the company had a 0.0029% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for BrightGene Bio Medical, which you can use to evaluate the volatility of the firm. Please confirm BrightGene Bio's Risk Adjusted Performance of (0.01), standard deviation of 3.74, and Mean Deviation of 2.6 to double-check if the risk estimate we provide is consistent with the expected return of 0.0107%.
  
The current year's Other Stockholder Equity is expected to grow to about 21.5 M, whereas Total Stockholder Equity is forecasted to decline to about 1.4 B. . BrightGene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0029

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns688166

Estimated Market Risk

 3.72
  actual daily
33
67% of assets are more volatile

Expected Return

 0.01
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.0
  actual daily
0
Most of other assets perform better
Based on monthly moving average BrightGene Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BrightGene Bio by adding BrightGene Bio to a well-diversified portfolio.
Price Book
5.1848
Enterprise Value Ebitda
66.0775
Price Sales
10.0354
Shares Float
259.2 M
Wall Street Target Price
44.21

BrightGene Bio Valuation on June 5, 2023

It is possible to determine the worth of BrightGene Bio on a given historical date. On June 5, 2023 BrightGene was worth 22.55 at the beginning of the trading date compared to the closed value of 23.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BrightGene Bio stock. Still, in general, we apply an absolute valuation method to find BrightGene Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BrightGene Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BrightGene Bio's related companies.
 Open High Low Close Volume
  22.67    22.77    22.17    22.48    3,166,281  
06/05/2023
  22.55    23.23    22.06    23.04    4,306,668  
  23.18    23.18    22.29    22.29    2,948,004  
Backtest BrightGene Bio  |  BrightGene Bio History  |  BrightGene Bio Valuation   PreviousNext  
Open Value
22.55
23.04
Closing Value
33.71
Upside

BrightGene Bio Trading Date Momentum on June 5, 2023

On June 06 2023 BrightGene Bio Medical was traded for  22.29  at the closing time. The highest price during the trading period was 23.18  and the lowest recorded bid was listed for  22.29 . The volume for the day was 2.9 M. This history from June 6, 2023 contributed to the next trading day price decline. The daily price change to the next closing price was 3.26% . The overall trading delta to the current price is 4.43% .

BrightGene Bio Medical Fundamentals Correlations and Trends

By evaluating BrightGene Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BrightGene Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BrightGene financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About BrightGene Bio Stock history

BrightGene Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BrightGene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BrightGene Bio Medical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BrightGene Bio stock prices may prove useful in developing a viable investing in BrightGene Bio
Last ReportedProjected for Next Year
Common Stock Shares Outstanding485.8 M340.7 M
Net Income Applicable To Common Shares275.6 M141.5 M

BrightGene Bio Quarterly Net Working Capital

724.85 Million

BrightGene Bio Stock Technical Analysis

BrightGene Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of BrightGene Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BrightGene Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

BrightGene Bio Period Price Range

Low
January 15, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

BrightGene Bio Medical cannot be verified against its exchange. Please verify the symbol is currently traded on Shanghai Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

BrightGene Bio January 15, 2025 Market Strength

Market strength indicators help investors to evaluate how BrightGene Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BrightGene Bio shares will generate the highest return on investment. By undertsting and applying BrightGene Bio stock market strength indicators, traders can identify BrightGene Bio Medical entry and exit signals to maximize returns

BrightGene Bio Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for BrightGene Bio's price direction in advance. Along with the technical and fundamental analysis of BrightGene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BrightGene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for BrightGene Stock analysis

When running BrightGene Bio's price analysis, check to measure BrightGene Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightGene Bio is operating at the current time. Most of BrightGene Bio's value examination focuses on studying past and present price action to predict the probability of BrightGene Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightGene Bio's price. Additionally, you may evaluate how the addition of BrightGene Bio to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators